ClinicalTrials.gov
public full text
Public Domain
Low-dose S-Ketamine and Postpartum Depression in Parturients With Prenatal Depression
Prenatal depression is an important risk factor of postpartum depression. Low-dose ketamine has been used for depression treatment. As a stereoisomer of ketamine, s-ketamine has similar effects to ketamine in anti-depression. We speculate that, for pregnant women with prenatal depression, low-dose s-ketamine infusion after childbirth may reduce the incidence of postpartum depression.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Low-dose S-ketamine in Women With Prenatal Depression#840453
- Phubbing in pregnancy as a predictor of postpartum depressive symptoms: preliminary results.#1159072
- Prenatal exposure to maternal depression and antidepressants and neurodevelopmental outcomes: A population cohort study.#1146965
- Prenatal exposure to maternal depression and antidepressants and neurodevelopmental outcomes: A population cohort study#1135358
- Perinatal Thymic DYsregulation: Characterization of Perinatal Mood Episodes#838952
Record · ID 1339458
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive